Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Plain Language Summary section removed from the study page, removing the lay-friendly overview of the trial for general readers. This reduces quick, accessible understanding of the study’s purpose and design for non-experts.
    Difference
    0.0%
    Check dated 2026-08-17T17:59:29.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor version update to the page's documentation/template.
    Difference
    0.0%
    Check dated 2026-08-10T15:30:41.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.3 to v3.6.4, indicating a minor version update to the underlying page.
    Difference
    0.0%
    Check dated 2026-07-27T06:39:37.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed, replacing Revision: v3.6.2. This appears to be an update to the document version without changes to the study content or its features.
    Difference
    0.0%
    Check dated 2026-07-05T14:47:08.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page's Revision label changed from v3.6.0 to v3.6.2, signaling a small update to the underlying software/content version.
    Difference
    0.0%
    Check dated 2026-06-28T08:57:32.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The study page adds new sections for How to Read a Study Record, Common Questions, and How to Join a Study, and updates the Intervention/Treatment labeling; the Revision line updates from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-13T17:39:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.